Russia prepares for mass coronavirus vaccination campaign in October

Published: 19:25 BST, 1 August 2020 | Updated: 19:55 BST, 1 August 2020

A state research facility in Moscow, the Gamaleya Institute, completed clinical trials of the vaccine and is working on getting it registered. 

Health Minister Mikhail Murashko said: ‘We plan wider vaccinations for October’ after outlining his plan to give the vaccine to teachers and doctors first. 

The Gamaleya Institute, a state research facility in Moscow, has finished clinical trials for a potential vaccine which Russia plans to roll out in October

However, some experts have expressed concern that Russia is moving too fast on developing a vaccine, without making sure it is safe, in order to win national prestige. 

US infectious disease expert Anthony Fauci, said yesterday that it was unlikely the US would use a vaccine developed by Russia or China because of different regulatory systems.

He told a Congressional hearing: ‘I do hope that the Chinese and the Russians are actually testing the vaccine before they are administering the vaccine to anyone.’ 

‘Claims of having a vaccine ready to distribute before you do testing, I think, is problematic, at best.’ 

Russia was also reported to have been involved in hacking coronavirus research labs in the US and the UK in May this year. 

The US Cybersecurity and Infrastructure Security Agency and the UK’s National Cyber Security Centre did not name any countries but Sky News said the culprits are understood to include China, Russia and Iran. 

The joint advisory said coronavirus research was targeted as the first country to develop a vaccine will undoubtedly achieve huge diplomatic and geo-political influence.

Worldwide countries are in a race to create a vaccine with over 20 currently in clinical trials. 

At least four are in final Phase three human trials, according to World Health Organisation data, including three developed in China and another in Britain. 

The UK has already ordered 100 million doses of a vaccine developed by the University of Oxford.   

Share what you think

The views expressed in the contents above are those of our users and do not necessarily reflect the views of MailOnline.

We will automatically post your comment and a link to the news story to your Facebook timeline at the same time it is posted on MailOnline. To do this we will link your MailOnline account with your Facebook account. We’ll ask you to confirm this for your first post to Facebook.

You can choose on each post whether you would like it to be posted to Facebook. Your details from Facebook will be used to provide you with tailored content, marketing and ads in line with our Privacy Policy.


News – Russia prepares for mass coronavirus vaccination campaign in October

Leave a Reply

Your email address will not be published. Required fields are marked *